Jeffrey D. Bradley, MD, FACR, FASTRO


Titles and Roles

James W. Keller Distinguished Professor in Radiation Oncology
Emory University School of Medicine
Radiation Oncologist
Lung Cancer
Cardiac Tumors
Emory Proton Therapy Center
Research Program
Discovery and Developmental Therapeutics


Jeffrey D. Bradley, MD, FACR, FASTRO, is James W. Keller Distinguished Professor in Radiation Oncology at Emory University School of Medicine.

As a board certified radiation oncologist, Dr. Bradley specializes in thoracic malignancies with a focus on stereotactic body radiation therapy and proton beam therapy. He is principal investigator of a number of transformational clinical trials for lung cancer patients.

Prior to Emory, Dr. Bradley was at Washington University School of Medicine in St. Louis where he was the S. Lee Kling Endowed Professor of Radiation Oncology, clinical director of the Kling Proton Center, and chief of the Radiation Oncology Thoracic Cancer Service. At Barnes Jewish in St Louis, he led the development of the first single room proton center in the world.

Dr. Bradley is Lung Cancer Committee Chair at NRG Oncology, the largest of the four adult National Clinical Trials Network Groups supported by the National Cancer Institute. He was named a fellow of the American Society for Radiation Oncology (ASTRO) in 2017. He served as chair of the lung/sarcoma section of oral boards with the American Board of Radiology for 10 years. He is also a founding member of the Particle Therapy Oncology Group of North America.

Dr. Bradley also holds professional memberships with American Society for Radiation Oncology, American Society for Clinical Oncology, and International Association for the Study of Lung Cancer.


Dr. Bradley earned his medical degree at the University of Arkansas for Medical Sciences. He completed his residency at the University of Chicago Medical Center.


Dr. Bradley's research focuses on clinical trials that have determined the radiation dose and radiation volume for patients with unresectable stage III lung cancer. He has authored a series of multi-institutional trials that have helped to set the standard of care for this patient population.


Dr. Bradley is the author of over 180 peer-reviewed publications.

  • PublicationsPublication Date

Additional Websites

Cascade Link   TOP